Clinical Outcomes of Small Cell Glioblastoma or Glioblastoma With Oligodendroglioma Component Treated With Radiation Therapy and Temozolomide

被引：0
|
作者：
Huang, J. [1 ]
Badiyan, S. N. [1 ]
Cai, C. [1 ]
Robinson, C. G. [1 ]
Dahiya, S. [1 ]
Tran, D. D. [1 ]
Kim, A. H. [1 ]
Dunn, G. P. [1 ]
Campian, J. L. [1 ]
Chicoine, M. R. [1 ]
Simpson, J. R. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.990
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2191
引用
收藏
页码：S293 / S294
页数：2
相关论文
共 50 条
  • [41] Combination treatment for glioblastoma with temozolomide, DFMO and radiation
    Alexiou, George A.
    Vartholomatos, Evrysthenis
    Tsamis, Konstantinos I.
    Peponi, Evangelia
    Markopoulos, George
    Papathanasopoulou, Vasiliki A.
    Tasiou, Ifigeneia
    Ragos, Vassilios
    Tsekeris, Periklis
    Kyritsis, Athanasios P.
    Galani, Vasiliki
    JOURNAL OF BUON, 2019, 24 (01): : 397 - 404
  • [42] Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
    Mallick, Supriya
    Gandhi, Ajeet Kumar
    Joshi, Nikhil P.
    Kumar, Anupam
    Puri, Tarun
    Sharma, Daya Nand
    Haresh, Kunhi Parambath
    Gupta, Subhash
    Julka, Pramod Kumar
    Rath, Goura Kisor
    Sarkar, Chitra
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2015, 36 (02) : 99 - 104
  • [43] VEGF modulation by radiation and temozolomide in glioblastoma cells
    Gage, D. L.
    McBride, W.
    Lai, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S216 - S216
  • [44] Radiation plus Temozolomide in Patients with Glioblastoma Reply
    Perry, James R.
    Laperriere, Normand
    Mason, Warren P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22): : 2197 - 2197
  • [45] Genomic Predictors of Infield and Marginal Failure for Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide: A Step Towards Personalized Radiation Fields?
    Holmes, J. A.
    Paulsson, A.
    Peiffer, A. M.
    Miller, L. D.
    Xu, J.
    Hinson, W. H.
    Lesser, G. J.
    Tatter, S. B.
    Debinski, W.
    Chan, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S291 - S292
  • [46] Hypofractionated Versus Standard Radiation Therapy With or Without Temozolomide for Older Glioblastoma Patients
    Fiorica, Francesco
    Colella, Maria
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (04): : 939 - 939
  • [47] Glioblastoma Expressing MGMT: Contribution of PaTrin-2 in Radiation Therapy With Temozolomide
    Viertl, D.
    Perillo-Adamer, F.
    Buchegger, F.
    Matzinger, O.
    Rueegg, C.
    Mirimanoff, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S701 - S701
  • [48] Phase I study of vandetanib with radiation therapy and temozolomide for newly diagnosed glioblastoma
    Drappatz, J.
    Norden, A. D.
    Wong, E. T.
    Lassman, A. B.
    Doherty, L.
    LaFrankie, D.
    Gerard, M.
    Phan, P.
    Schiff, D.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] PHASE I STUDY OF VANDETANIB WITH RADIATION THERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew
    Wong, Eric T.
    Doherty, Lisa
    LaFrankie, Debra
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Lassman, Andrew B.
    Schiff, David
    Batchelor, Tracy
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
  • [50] NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma
    Yahyanejad, Sanaz
    King, Henry
    Iglesias, Venus Sosa
    Granton, Patrick V.
    Barbeau, Lydie M. O.
    van Hoof, Stefan J.
    Groot, Arjan J.
    Habets, Roger
    Prickaerts, Jos
    Chalmers, Anthony J.
    Eekers, Danielle B. P.
    Theys, Jan
    Short, Susan C.
    Verhaegen, Frank
    Vooijs, Marc
    ONCOTARGET, 2016, 7 (27) : 41251 - 41264
12345